AsortinoBeta
Viatris Inc. logo

VTRSViatris Inc.

NASDAQStockHealthcareDrug Manufacturers - Specialty & Generic🇺🇸 United StatesISIN US92556V1061viatris.com
$16.880.35%
NASDAQ · at close Sep 4, 2026
Tokenized by
Backed Finance logoDinari Inc. logoReality logo
3 issuersOn
XLayer logoSolana logoTON logoEthereum logo
14 chains

Chart data are delayed by 15 minutes.

1D0.35%
1M4.63%
3M+6.16%
1Y+63.41%
3Y+56.44%
5Y+13.36%

Main metrics

$19.39B
$35.48<0.01% of mkt cap
235.80
-$0.37
2.84%
9.5M
0.88
$9.4352-week range$18.39

About VTRS

Viatris Inc. is a global healthcare company focused on expanding access to a broad range of medicines across multiple therapeutic areas. Its portfolio includes established prescription brands, generic and complex generic medicines, biosimilars, and over-the-counter consumer products that support treatment and disease management worldwide. Viatris serves patients and healthcare systems in developed and emerging markets through operations organized across Developed Markets, Greater China, JANZ, and Emerging Markets. The company also emphasizes reliable manufacturing, distribution, and supply continuity for essential therapies, helping connect more people to trusted medicines regardless of geography or circumstance. Headquartered in Canonsburg, Pennsylvania, Viatris operates as a diversified pharmaceutical business with a broad international footprint and a focus on scalable healthcare access.

Similar products

Elanco Animal Health Incorporated logo
ELANNYSE
$24.50+0.33%
Elanco Animal Health Incorporated
Backed Finance logoReality logo
2 issuers · 11 chains
Hims & Hers Health, Inc. Class A Common Stock logo
HIMSNYSE
$27.710.40%
Hims & Hers Health, Inc. Class A Common Stock
Ondo Finance logoBacked Finance logoRobinhood logo
6 issuers · 15 chains
Liquidia Corporation logo
LQDANASDAQ
$68.66+0.04%
Liquidia Corporation
Reality logo
1 issuer · 1 chain
Neurocrine Biosciences, Inc. logo
NBIXNASDAQ
$155.641.71%
Neurocrine Biosciences, Inc.
Backed Finance logoReality logo
2 issuers · 11 chains